Article Details

Eli Lilly taps Verge Genomics in ALS deal worth $25M upfront

Retrieved on: 2021-07-08 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly taps Verge Genomics in ALS deal worth $25M upfront. View article details on hiswai:

Excerpt

The neuroscience-focused drug discoverer will pick up $25 million in an upfront fee, equity and near-term payments, but stands to collect up to $694 ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up